Making INformed Decisions in Gaze and Postural Stability: A Pilot Feasibility Study (MINDGAPS)

April 1, 2024 updated by: Brian Loyd, University of Montana

Making INformed Decisions in Gaze and Postural Stability (MINDGAPS): A Novel System for Improving Personalized Care and Patient Adherence in Vestibular Rehabilitation

The proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary efficacy of a novel intervention system for improving vestibular function and dizziness in community-dwelling older adults, 2) assess the safety and feasibility of the this system, and 3) assess the acceptability and implementation potential of this system, prior to a large-scale, R01-level investigation.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Deficits in gaze and postural stability are closely linked with vestibular hypofunction. These deficits result in dizziness and poor balance, increasing the risk for falls and other poor health outcomes. Vestibular hypofunction occurs with several conditions and is increasingly prevalent with advancing age. An estimated 85% of people over the age of 80 experience vestibular hypofunction. As with many age-related health challenges (e.g. sarcopenia, osteoporosis, cardiovascular disease), exercise is widely recommended to remediate the effects of vestibular hypofunction. Vestibular rehabilitation has demonstrated efficacy at improving vestibular hypofunction in tightly controlled clinical trials, but the effectiveness in practice is limited by two major barriers: 1) reduced patient adherence to the exercise program, and 2) inability to precisely assess vestibular function. These are overlapping challenges; lack of access to vestibular function assessments impedes effective dosing of rehabilitation as well as monitoring of patient adherence and progress. Thus, personalization and monitoring-essential ingredients of nearly any health or exercise regimen-are functionally missing in vestibular rehabilitation practice.

For this proposal, the investigators have developed the Making INformed Decisions in Gaze and Postural Stability (MINDGAPS) system, which utilizes wearable sensor technology to provide simple, precise measures of gaze and postural stability, as well as remote monitoring of patient adherence to vestibular exercises. Additionally, MINDGAPS leverages NIH Toolbox data to display patient status compared to normative values and to indicate progress over time relative to measurement error. This enables the application of two innovative behavioral science principles aimed at facilitating patient adherence: 1) social norming; comparison of a patient to her or his peers, and 2) frequent monitoring of progress and outcomes. This study is designed to examine the preliminary efficacy of the MINDGAPS system, along with the feasibility, safety, and acceptability of its use in practice. This study will use a single cohort, double-baseline design (n=30 older adults with vestibular hypofunction). Following, the baseline (control) phase, all participants will complete 6 weeks of individualized vestibular rehabilitation informed by the MINDGAPS system. Preliminary efficacy of the intervention will be examined by comparing computerized Dynamic Visual Acuity (cDVA) scores during the intervention phase to cDVA scores during the baseline phase. Feasibility and safety of the intervention will be examined relative to a priori thresholds for recruitment, retention and adherence rates, as well as recording of adverse events. Finally, the acceptability and remote/telehealth capability of the system will be explored using a mixed methods analysis, which will inform system refinement in preparation for a future R01 submission (phase II clinical trial).

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Reports issues with dizziness or imbalance
  • Ability to stand independently
  • Presence of peripheral vestibular hypofunction as indicated by examination with video nystagmography, video head impulse testing, or dynamic visual acuity testing.

Exclusion Criteria:

  • cervical spine disorders
  • vertebral or carotid artery dissection
  • blindness
  • peripheral or central oculomotor palsy
  • centrally mediated vestibular dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Computerized Dynamic Visual Acuity (cDVA)
Time Frame: through study completion, an average of 12 weeks
computerized measure of functional gaze stability
through study completion, an average of 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Instrumented postural sway assessment
Time Frame: through study completion, an average of 12 weeks
instrumented assessment of static postural stability
through study completion, an average of 12 weeks
Video head impulse testing (vHIT)
Time Frame: through study completion, an average of 12 weeks
computerized assessment of vestibulo-ocular reflex function
through study completion, an average of 12 weeks
Functional Gait Assessment (FGA)
Time Frame: through study completion, an average of 12 weeks
The Functional Gait Assessment (FGA) is a 10-item measure that examines dynamic stability during various walking tasks on a marked 6-m (20-ft) length and 12-inch wide walkway. Each item is rated from 0-3 with higher scores indicating better dynamic stability. Tasks within the FGA require head and/or body motion during walking activities which will be assessed using body-worn 3D inertial measurement units.
through study completion, an average of 12 weeks
Activities-specific Balance Confidence Scale (ABC)
Time Frame: through study completion, an average of 12 weeks
The Activity Specific Balance Confidence Scale (ABC) is a 16-item self-reported measure of balance confidence in performing various activities of daily living. Each question requires an individual to grade his or her self on a scale of 0 to 100 percent for their level of confidence and higher scores indicate greater balance confidence in performing these activities.
through study completion, an average of 12 weeks
Dizziness Handicap Inventory (DHI)
Time Frame: through study completion, an average of 12 weeks
Dizziness Handicap Inventory (DHI): The DHI is a self assessment inventory designed to evaluate the self-perceived handicap effects imposed by dizziness or unsteadiness and has documented test-retest and internal consistency reliability. The DHI consists of 25 questions subgroup into functional, emotional, and physical components. The total score ranges from 0-100, with higher scores indicating greater handicap.
through study completion, an average of 12 weeks
Mini- Balance Evaluation Systems Test (BESTest)
Time Frame: through study completion, an average of 12 weeks
the 14-item Mini-BESTest which includes four sections (anticipatory postural adjustments, reactive postural responses, sensory orientation, and stability in gait) relevant to postural control and stability. The maximum possible score is 28 with higher scores indicating better balance. Tasks within the Mini-BEST test require head and/ or body motion, which will be assessed using body-worn 3D inertial measurement units.
through study completion, an average of 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Two minute walk test (2MWT)
Time Frame: through study completion, an average of 12 weeks
Maximal distance walked along a 50 foot course in two minutes. During the test head and/or body motion will be assessed using body-worn 3D inertial measurement units.
through study completion, an average of 12 weeks
Community Ambulatory Task (CAT)
Time Frame: through study completion, an average of 12 weeks
Walking task that simulates community ambulation. During the task head and/or body motion during walking activities which will be assessed using body-worn 3D inertial measurement units.
through study completion, an average of 12 weeks
Life Space Mobility Assessment (LSA)
Time Frame: through study completion, an average of 12 weeks
patient reported questionnaire examining community mobility. The maximum possible score is 40 with higher scores indicating better life space mobility.
through study completion, an average of 12 weeks
Role Participation Questionnaire
Time Frame: through study completion, an average of 12 weeks
patient reported questionnaire assessing participant role in society. The questionnaire asks 17 questions with lower scores indicating greater societal role.
through study completion, an average of 12 weeks
General Well Being Scale
Time Frame: through study completion, an average of 12 weeks
patient reported questionnaire assessing psychological health. Consists of 18 questions with scores ranging from 0-110 and higher scores indicating better well-being.
through study completion, an average of 12 weeks
Visual Analog Scale of Dizziness and Unsteadiness
Time Frame: through study completion, an average of 12 weeks
patient report of severity of dizziness and unsteadiness. Participants are asked to draw a single line on a 10 cm line with a higher number indicating greater dizziness or unsteadiness.
through study completion, an average of 12 weeks
Physical Activity Tracker
Time Frame: through study completion, an average of 12 weeks
daily step counts obtained with wearable device.
through study completion, an average of 12 weeks
National Aeronautics and Space Administration (NASA) task load index
Time Frame: through study completion, an average of 12 weeks
patient reported measure of difficulty and cognitive load of intervention. Scores range from 0-20 with higher scores indicating greater task load.
through study completion, an average of 12 weeks
System Usability Scale
Time Frame: through study completion, an average of 12 weeks
patient reported measure of usability of intervention system. Scores range from 0-100 with higher scores indicating greater usability.
through study completion, an average of 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2022

Primary Completion (Estimated)

March 31, 2025

Study Completion (Estimated)

March 31, 2025

Study Registration Dates

First Submitted

May 11, 2022

First Submitted That Met QC Criteria

May 21, 2022

First Posted (Actual)

May 26, 2022

Study Record Updates

Last Update Posted (Actual)

April 3, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB #10-22
  • R21DC020251 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vestibular Hypofunction

Subscribe